BORSARI, CHIARA
BORSARI, CHIARA
Dipartimento di Scienze Farmaceutiche
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antimicrobial and antiradical agents
2024 F. Annunziata, S. Vicinanza, L. Mombelli, S. Donzella, G. Meroni, C. Borsari, M.L. Contente, P.A. Martino, P. Conti, A. Pinto, S. Dallavalle, L. Tamborini
Tyrosol and hydroxytyrosol carbonates and carbamates as novel antiradical and antimicrobial agents: a chemo-enzymatic flow synthesis
2024 S. Vicinanza, L. Mombelli, F. Annunziata, S. Donzella, M.L. Contente, C. Borsari, G. Meroni, P.A.M. Martino, A. Pinto, L. Tamborini
Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond
2024 R.A.M. Serafim, M. Gehringer, C. Borsari
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS
2024 C. Borsari, M. Wymann
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K
2024 M. Wymann, C. Borsari
Boosting the Impact of EFMC Young Scientists Network Through the Creation of Working Groups
2024 M. Mari, C. Lanthier, M. Proj, E.J. Donckele, L. Josa‐culleré, K. Goncharenko, S. Leroy, B. Matagne, S.M. Mckenna, C. Borsari
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents
2024 A.I. Corfu, N. Santarem, S. Luelmo, G. Mazza, A. Greco, A. Altomare, G. Ferrario, G. Nasta, O. Keminer, G. Aldini, L. Tamborini, N. Basilico, S. Parapini, S. Gul, A. Cordeiro-da-Silva, P. Conti, C. Borsari
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα
2024 W.T. Jauslin, M. Schild, T. Schaefer, C. Borsari, C. Orbegozo, L. Bissegger, S. Zhanybekova, D. Ritz, A. Schmidt, M. Wymann, D. Gillingham
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antiradical and antimicrobial agents
2024 S. Vicinanza, L. Mombelli, F. Annunziata, S. Donzella, M.L. Contente, C. Borsari, P. Conti, G. Meroni, F. Molinari, P.A.M. Martino, A. Pinto, L. Tamborini
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K | [TRIAZINDERIVAT ALS REVERSIBLE UND IRREVERSIBLE KOVALENTE PI3K-HEMMER]
2024 C. Borsari, M. Wymann
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS | [VERFAHREN ZUR IDENTIFIZIERUNG VON PI3-KINASE-ALPHA-INHIBITOREN]
2024 C. Borsari, M. Wymann
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K | [TRIAZINDERIVAT ALS KOVALENTE INHIBITOREN VON PI3K]
2024 M. Wymann, C. Borsari
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K
2024 C. Borsari, M. Wymann
Rapid, potent, and persistent covalent chemical probes to deconvolute PI3Kα signaling
2024 L. Bissegger, T.A. Constantin, E. Keles, L. Raguž, I. Barlow-Busch, C. Orbegozo, T. Schaefer, V. Borlandelli, T. Bohnacker, R. Sriramaratnam, A. Schäfer, M. Gstaiger, J.E. Burke, C. Borsari, M.P. Wymann
Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives
2023 A. Galbiati, A. Zana, C. Borsari, M. Persico, S. Bova, O. Tkachuk, A.I. Corfu, L. Tamborini, N. Basilico, C. Fattorusso, S. Bruno, S. Parapini, P. Conti
Chemo-enzymatic flow synthesis of tyrosol and hydroxytyrosol carbonates and carbamates as novel antiradical and antimicrobial agents
2023 S. Vicinanza, F. Annunziata, L. Mombelli, D. Pecora, S. Donzella, M.L. Contente, G. Meroni, V.M. Sora, P.A.M. Martino, C. Borsari, A. Pinto, L. Tamborini
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells
2023 A. Galbiati, S. Bova, R. Pacchiana, C. Borsari, M. Persico, A. Zana, S. Bruno, M. Donadelli, C. Fattorusso, P. Conti
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange
2023 L. Ferrins, M.E. Olson, K. Haranahalli, M.C. Grenier-Davies, M.W. Boudreau, B. Matagne, E.J. Donckele, C. Borsari
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange
2023 L. Ferrins, M.E. Olson, K. Haranahalli, M.C. Grenier-Davies, M.W. Boudreau, B. Matagne, E.J. Donckele, C. Borsari
Stereospecific Synthesis of Substituted Sulfamidates as Privileged Morpholine Building Blocks
2023 U. Stojiljkovic, C. Meyer, P. Boulay, P. Hebeisen, D. Rageot, M.P. Wymann, C. Borsari